Pharmacy Law and Regulations Flashcards
7 cards from real PTCE practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Pharmacy Law and Regulations flashcards as text
Which federal law first required that prescription drugs be dispensed only with a valid prescription, separating them from OTC products?
Answer: Durham-Humphrey Amendment of 1951
The Durham-Humphrey Amendment of 1951 established the legal distinction between prescription and over-the-counter drugs.
A patient requests a 90-day supply of a Schedule III medication. The maximum days' supply a pharmacy can dispense on a single written prescription is:
Answer: 90 days
Schedule III and IV prescriptions may be dispensed for up to a 90-day supply per fill and refilled up to 5 times within 6 months.
The term 'DAW-1' on a prescription means:
Answer: Dispense as written — no generic substitution per prescriber
DAW-1 (Dispense As Written code 1) indicates the prescriber mandates the brand-name product and no generic substitution is permitted.
Under USP , a low-risk compounded sterile preparation with no more than 12 hours storage at room temperature must be used within:
Answer: 12 hours
USP allows low-risk CSPs stored at controlled room temperature to have a BUD of up to 12 hours.
Which agency enforces the Occupational Safety and Health Administration (OSHA) hazardous drug handling standards in pharmacies?
Answer: OSHA itself
OSHA enforces its own hazardous drug handling regulations, including requirements for PPE and safe handling of antineoplastic agents in pharmacy settings.
A pharmacist is on vacation and the pharmacy has only technicians present. Which action is legally permissible?
Answer: None of the above — the pharmacy must be closed
A licensed pharmacist must be present for dispensing, final verification, and counseling; a pharmacy cannot legally operate with only technicians.
The MedWatch program is administered by the FDA for the purpose of:
Answer: Reporting serious adverse drug events and product problems
MedWatch is the FDA's safety reporting program for healthcare professionals and consumers to report adverse drug reactions and product defects.